Durham, NC · Founded 2018 · Privately Held (backing)
Developer of bioengineered reconstructive biomaterials designed to enable the use of a person's tissue in surgical procedures. inSoma Bio is based in Durham, NC and was founded in 2018. Its last reported valuation was $18.7 million in May 2024. It has raised $7.8 million across 3 recorded rounds; the latest was a $2.7 million seed round in Sep 2025.
Last reported valuation
$18.7M
Oct 2026
Priced at
—
Total raised
$7.8M
Last round
Seed Round
Sep 2025
Cap table — not yet on record
inSoma Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of inSoma Bio with a free account
·The complete investor list: 23 names
·Watch inSoma Bio: the Monday email on marks, rounds and moves